DR. SAMIR MUKUND PARIKH, M.D.
Osteopathic Medicine at Brookline Ave, Boston, MA
License number
Massachusetts 217295
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
330 Brookline Ave, Boston, MA 02215
Phone
(617) 667-2147
(617) 667-7581 (Fax)
(617) 667-7581 (Fax)
Personal information
See more information about SAMIR MUKUND PARIKH at radaris.comName
Address
Phone
52 Westland Ave, Winchester, MA 01890
40 Jamaicaway, Jamaica Plain, MA 02130
1047 Southern Artery APT 60, Quincy, MA 02169
11 Dotty Ann Dr, Framingham, MA 01701
40 Jamaicaway, Jamaica Plain, MA 02130
Professional information
Methods And Compositions For The Treatment And Diagnosis Of Diseases Characterized By Vascular Leak, Hypotension, Or A Procoagulant State
US Patent:
2013025, Sep 26, 2013
Filed:
Sep 10, 2012
Appl. No.:
13/608606
Inventors:
Vikas P. Sukhatme - Newton MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Samir M. Parikh - Roslindale MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Samir M. Parikh - Roslindale MA, US
Assignee:
Beth Israel Deaconess Medical Center, Inc. - Boston MA
International Classification:
C12Q 1/68
US Classification:
506 2, 435 612, 435 611, 506 9
Abstract:
Disclosed herein are methods for treating a vascular leak disorder, hypotension, or a procoagulant state using angiopoietin-2 (Ang-2) antagonist compounds. Also disclosed are methods for treating a vascular leak disorder associated with high dose IL-2 therapy using angiopoietin-2 antagonist compounds. Methods for diagnosing and monitoring vascular leak disorders, hypotension, or a procoagulant state that include the measurement of Ang-2 polypeptide or nucleic acid levels are also disclosed. Methods for inducing a vascular leak using an Ang-2 agonist are also disclosed.
Methods And Compositions For The Treatment And Diagnosis Of Diseases Characterized By Vascular Leak, Hypotension, Or A Procoagulant State
US Patent:
2010022, Sep 2, 2010
Filed:
Jan 26, 2009
Appl. No.:
12/359954
Inventors:
Vikas P. Sukhatme - Newton MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Samir M. Parikh - Roslindale MA, US
S. Ananth Karumanchi - Chestnut Hill MA, US
Samir M. Parikh - Roslindale MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61K 39/395, A61P 9/00, A61P 7/02
US Classification:
4241331, 4241301, 4241581
Abstract:
Disclosed herein are methods for treating a vascular leak disorder, hypotension, or a procoagulant state using angiopoietin-2 (Ang-2) antagonist compounds. Also disclosed are methods for treating a vascular leak disorder associated with high dose IL-2 therapy using angiopoietin-2 antagonist compounds. Methods for diagnosing and monitoring vascular leak disorders, hypotension, or a procoagulant state that include the measurement of Ang-2 polypeptide or nucleic acid levels are also disclosed. Methods for inducing a vascular leak using an Ang-2 agonist are also disclosed.
Methods And Compositions For The Treatment And Diagnosis Of Diseases Characterized By Vascular Leak, Hypotension, Or A Procoagulant State
US Patent:
2007015, Jul 5, 2007
Filed:
Sep 12, 2006
Appl. No.:
11/519954
Inventors:
Vikas Sukhatme - Newton MA, US
S. Karumanchi - Chestnut Hill MA, US
Samir Parikh - Roslindale MA, US
S. Karumanchi - Chestnut Hill MA, US
Samir Parikh - Roslindale MA, US
Assignee:
Beth Israel Deaconess Medical Center - Boston MA
International Classification:
A61K 39/395, G01N 33/53, A61K 31/573, A61K 31/43, A61K 31/545
US Classification:
424146100, 514171000, 514012000, 514192000, 514200000, 435007100
Abstract:
Disclosed herein are methods for treating a vascular leak disorder, hypotension, or a procoagulant state using angiopoietin-2 (Ang-2) antagonist compounds. Also disclosed are methods for treating a vascular leak disorder associated with high dose IL-2 therapy using angiopoietin-2 antagonist compounds. Methods for diagnosing and monitoring vascular leak disorders, hypotension, or a procoagulant state that include the measurement of Ang-2 polypeptide or nucleic acid levels are also disclosed. Methods for inducing a vascular leak using an Ang-2 agonist are also disclosed.
Dr. Samir M Parikh, Boston MA - MD (Doctor of Medicine)
Specialties:
Sports Medicine, Nephrology, Osteopathic Manipulative Therapy
Age:
49
Address:
330 Brookline Ave, Boston 02215
(617) 667-2147 (Phone), (617) 667-7581 (Fax)
(617) 667-2147 (Phone), (617) 667-7581 (Fax)
Certifications:
Internal Medicine, 2005, Nephrology, 2006, Osteopathic Manipulative Medicine, Sports Medicine
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston 02215
Education:
Medical School
Vanderbilt University School Of Medicine
Graduated: 2001
Vanderbilt University School Of Medicine
Graduated: 2001
Samir Mukund Parikh, Boston MA
Specialties:
Nephrologist
Address:
330 Brookline Ave, Boston, MA 02215
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Samir Mukund Parikh, Boston MA
Specialties:
Internal Medicine, Nephrology, Pulmonary Disease
Work:
Beth Israel Deaconess Medical Center
330 Brookline Ave, Boston, MA 02215
330 Brookline Ave, Boston, MA 02215
Education:
Vanderbilt University (2001)
Methods And Compositions For The Treatment And Diagnosis Of Systemic Anthrax Infection
US Patent:
2011011, May 12, 2011
Filed:
Mar 23, 2009
Appl. No.:
12/934430
Inventors:
Samir M. Parikh - Roslindale MA, US
International Classification:
A61K 39/395, G01N 33/68, C12Q 1/68, A61K 38/02, A61K 31/496, A61K 31/65, A61K 31/7048, A61K 38/14, A61K 31/545, A61K 38/48, A61P 31/04
US Classification:
4241331, 436 86, 435 6, 435 71, 4241581, 514 24, 4241451, 4241421, 51425308, 514154, 514 29, 514 31, 514192, 424 9464
Abstract:
The present invention features methods and kits that utilize Ang-2 antagonists for the treatment, inhibition, and prevention of a systemic anthrax infection. The invention described herein also features methods for the diagnosis of a systemic anthrax infection by detecting elevated levels of Ang-2 in the serum of a subject.